Literature DB >> 12070432

Oxidative stress in the blood of patients with alcohol-related liver cirrhosis.

Agnieszka Szuster-Ciesielska1, Jadwiga Daniluk, Martyna Kandefer-Szerszeń.   

Abstract

BACKGROUND: Ethanol may increase the production of reactive oxygen species (ROS) in the liver, which results in the development of alcoholic liver disease (ALD). Cytokine-activated blood leukocytes may also participate in this process. The aim of our study was to evaluate the oxidative stress level in the blood of patients with alcoholic liver cirrhosis. MATERIAL/
METHODS: Blood neutrophils from 16 patients with compensated alcoholic liver cirrhosis and 28 patients with decompensated were evaluated for their ability to produce superoxide anion and hydrogen peroxide spontaneously and after PMA induction, in comparison to controls (16 healthy persons). Serum catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity were also measured in both groups of patients and in the controls.
RESULTS: The neutrophils from patients with compensated liver cirrhosis spontaneously produced a normal level of O2*- and a high level of H2O2, but exhibited a defect in PMA-induced O2*- production. The neutrophils from patients with decompensated liver cirrhosis spontaneously produced more O2*- and H2O2 than the controls, but the PMA response was weak. There were no changes in the expression of GPx, but enhanced SOD activity was observed in the serum of patients with decompensated alcoholic liver cirrhosis. Increased CAT activity was detected only in serum from patients with compensated liver cirrhosis.
CONCLUSIONS: These data point to oxidative stress in the blood of patients with decompensated alcoholic cirrhosis, since increased resting production of ROS in neutrophils was not accompanied by increased GPx and CAT activity in serum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070432

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

2.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

3.  Oxidative stress and S100B protein in cirrhotic children.

Authors:  Luciana Ribeiro; Ana Cristina Andreazza; Mirian Salvador; Themis Reverbel da Silveira; Sandra Vieira; Daniel Bocchese Nora; Cleonice Bosa; Francesca Di Napoli; Débora Vigevani Schaf; Diogo Onofre Souza; Luis Valmor Cruz Portela; Flávio Kapczinski
Journal:  Neurochem Res       Date:  2007-05-19       Impact factor: 3.996

4.  Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat.

Authors:  Jin-Hong Han; Hong-Zhao Tian; Yang-Yang Lian; Yi Yu; Cheng-Biao Lu; Xin-Min Li; Rui-Ling Zhang; Haiyun Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-15       Impact factor: 2.570

Review 5.  Experimental models of metabolic and alcoholic fatty liver disease.

Authors:  Delfin Gerard Buyco; Jasmin Martin; Sookyoung Jeon; Royce Hooks; Chelsea Lin; Rotonya Carr
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

6.  Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.

Authors:  Ming Shu; Xiao-Rong Hu; Zuo-An Hung; Dam-Dan Huang; Shun Zhang
Journal:  Mol Med Rep       Date:  2016-02-10       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.